Pegylated liposomal doxorubicin and carboplatin versus paclitaxel and carboplatin as first-line treatment for Chinese patients with ovarian cancer: A multi-center, randomized, open-label trial

被引：0
|
作者：
Shen, Yuanming
Kong, Beihua
Xia, Bairong
Wang, Fei
Yin, Rutie
Li, Qingshui
Yue, Ying
Kang, Shan
He, Liping
Wang, Ke
Meng, Yuanguang
Wang, Shixuan
Qu, Pengpeng
Huang, Xianghua
Guo, Ruixia
Yan, Ping
Pan, Mei
Lou, Ge
Cheng, Wenjun
Xie, Xing
机构：
[1] Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou, Zhejiang, Peoples R China
[2] Shandong Univ, Qilu Hosp, Jinan, Peoples R China
[3] Univ Sci & Technol China, Div Life Sci & Med, Affiliated Hosp 1, Hefei, Peoples R China
[4] Shandong Prov Hosp, Jinan, Peoples R China
[5] Sichuan Univ, West China Univ Hosp 2, Chengdu, Sichuan, Peoples R China
[6] Shandong Canc Hosp & Inst, Jinan, Peoples R China
[7] Jilin Univ, Affiliated Hosp 1, Changchun, Peoples R China
[8] Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
[9] Hebei Tumor Hosp, Shijiazhuang, Hebei, Peoples R China
[10] Guizhou Med Univ, Affiliated Canc Hosp, Guiyang, Guizhou, Peoples R China
[11] Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China
[12] Chinese Peoples Liberat Army Gen Hosp, Dept Gynecol & Obstet, Beijing, Peoples R China
[13] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China
[14] Tianjin Cent Hosp Gynecol & Obstet, Tianjin, Peoples R China
[15] Hebei Med Univ, Hosp 2, Shijiazhuang, Hebei, Peoples R China
[16] Zhengzhou Univ, Affiliated Hosital 1, Zhengzhou, Peoples R China
[17] Hebei Gen Hosp, Shijiazhuang, Hebei, Peoples R China
[18] Maternal & Child Hlth Hosp Jiangxi Prov, Nanchang, Jiangxi, Peoples R China
[19] Harbin Med Univ, Canc Hosp, Harbin, Heilongjiang, Peoples R China
[20] Jiangsu Prov Hosp, Nanjing, Peoples R China
[21] Zhejiang Univ, Womens Hosp, Sch Med, Hangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5556
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III Trial
    Pignata, Sandro
    Scambia, Giovanni
    Ferrandina, Gabriella
    Savarese, Antonella
    Sorio, Roberto
    Breda, Enrico
    Gebbia, Vittorio
    Musso, Pietro
    Frigerio, Luigi
    Del Medico, Pietro
    Lombardi, Alessandra Vernaglia
    Febbraro, Antonio
    Scollo, Paolo
    Ferro, Antonella
    Tamberi, Stefano
    Brandes, Alba
    Ravaioli, Alberto
    Valerio, Maria Rosaria
    Aitini, Enrico
    Natale, Donato
    Scaltriti, Laura
    Greggi, Stefano
    Pisano, Carmela
    Lorusso, Domenica
    Salutari, Vanda
    Legge, Francesco
    Di Maio, Massimo
    Morabito, Alessandro
    Gallo, Ciro
    Perrone, Francesco
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27) : 3628 - 3635
  • [2] CARBOPLATIN PLUS PACLITAXEL VERSUS CARBOPLATIN PLUS PEGYLATED LIPOSOMAL DOXORUBICIN AS FIRST-LINE TREATMENT FOR PATIENTS WITH OVARIAN CANCER: THE MITO-2 (MULTICENTRE ITALIAN TRIALS IN OVARIAN CANCER) RANDOMIZED PHASE III TRIAL
    Pignata, S.
    Scambia, G.
    Savarese, A.
    Sorio, R.
    Breda, E.
    Ferrandina, G.
    Murgia, V.
    Tamberi, S.
    Signoriello, S.
    Di Maio, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 304 - 304
  • [3] A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer
    du Bois, A
    Lück, HJ
    Meier, W
    Adams, HP
    Möbus, V
    Costa, S
    Bauknecht, T
    Richter, B
    Warm, M
    Schröder, W
    Olbricht, S
    Nitz, U
    Jackisch, C
    Emons, G
    Wagner, U
    Kuhn, W
    Pfisterer, J
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (17): : 1320 - 1330
  • [4] Sequential combination of paclitaxel-carboplatin and paclitaxel-liposomal doxorubicin as a first-line treatment in patients with ovarian cancer - A multicenter phase II trial
    Potamianou, A
    Androulakis, N
    Papakotoulas, P
    Toufexi, H
    Latoufis, C
    Kouroussis, C
    Christofilakis, C
    Xenidis, N
    Georgoulias, V
    Polyzos, A
    ONCOLOGY, 2005, 69 (04) : 348 - 353
  • [5] Efficacy and safety of paclitaxel liposome versus paclitaxel in combination with carboplatin in the first-line chemotherapy for ovarian cancer: a multicenter, open-label, non-inferiority, randomized controlled trial
    Li, Rong
    Zhang, Hongping
    Li, Qingshui
    Yuan, Guangwen
    Zhou, Yanjie
    Yin, Rutie
    Wang, He
    Wang, Chunyan
    Huang, Yi
    Wang, Wei
    Yan, Xiaojian
    Wu, Lingying
    Zhou, Qi
    JOURNAL OF THE NATIONAL CANCER CENTER, 2024, 4 (02): : 135 - 141
  • [6] Paclitaxel plus nedaplatin vs. paclitaxel plus carboplatin in women with epithelial ovarian cancer: A multi-center, randomized, open-label, phase III trial
    Li, Li
    Zhuang, Qingqing
    Cao, Zeyi
    Yin, Rutie
    Zhu, Yaping
    Zhu, Lirong
    Xie, Xing
    Zhang, Youzhong
    Li, Li
    Wu, Qiang
    Zheng, Jianhua
    Zhou, Qi
    Li, Xiaoping
    Wu, Lingying
    Feng, Youji
    Wang, Changyu
    ONCOLOGY LETTERS, 2018, 15 (03) : 3646 - 3652
  • [7] Paclitaxel/carboplatin/gemcitabine as first-line treatment of ovarian cancer
    Hansen, SW
    Geertsen, F
    Stroyer, I
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 96 - 96
  • [8] Paclitaxel plus nedaplatin vs. paclitaxel plus carboplatin in women with epithelial ovarian cancer: A multi-center, randomized, open-label, phase III trial.
    Li, Li
    Zhuang, Qingqing
    Cao, Zeyi
    Yin, Ru Tie
    Zhu, Yaping
    Zhu, Lirong
    Xie, Xing
    Zhang, Youzhong
    Li, Li
    Wu, Qiang
    Zheng, Jianhua
    Zhou, Qi
    Li, Xiaoping
    Wu, Lingying
    Feng, Youji
    Wang, Changyu
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse
    Pujade-Lauraine, Eric
    Wagner, Uwe
    Aavall-Lundqvist, Elisabeth
    Gebski, Val
    Heywood, Mark
    Vasey, Paul A.
    Volgger, Birgit
    Vergote, Ignace
    Pignata, Sandro
    Ferrero, Annamaria
    Sehouli, Jalid
    Lortholary, Alain
    Kristensen, Gunnar
    Jackisch, Christian
    Joly, Florence
    Brown, Chris
    Le Fur, Nathalie
    du Bois, Andreas
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (20) : 3323 - 3329
  • [10] First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin
    Kristensen, GB
    Vergote, I
    Stuart, G
    Del Campo, JM
    Kaern, J
    Lopez, AB
    Eisenhauer, E
    Aavall-Lundquist, E
    Ridderheim, M
    Havsteen, H
    Mirza, MR
    Scheistroen, M
    Vrdoljak, E
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2003, 13 : 172 - 177
12345